[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, Belimumab has been studied and shown to be effective in improving renal outcomes in patients with lupus nephritis. Multiple studies and clinical trials have demonstrated that Belimumab can reduce proteinuria, improve renal response, and attenuate the decline in estimated glomerular filtration rate (eGFR) in patients with lupus nephritis. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]